We’ll help you find the highest quality medicine that you need.
is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.
Manufactured by: Marathon Pharmaceuticals, LLC and marketed by PTC Therapeutics
Active Ingredient(s): Deflazacort
Dosage Form: Tablet, oral
Strength: 6 mg, 18 mg, 30 mg, and 36 mg
FDA approved: February 9, 2017
More information about Emflaza:
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208684s000,208685s000lbl.pdf
is indicated for the treatment of adult patients with chronic HCV genotype 1, 2, 3, 4, 5 or 6 infection 1) without cirrhosis or with compensated cirrhosis and 2) with decompensated cirrhosis for use in combination with ribavirin.
Manufactured by: Gilead Sciences.Inc
Active Ingredient(s): Sofosbuvir and Velpatasvir
Dosage Form: Tablet, oral
Strength: Each Epclusa tablet contains 400 mg of Sofosbuvir and 100 mg of Velpatasvir.
FDA approved: June 28, 2016
More information about Epclusa:
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf
http://www.gilead.com/~/media/Files/pdfs/medicines/liver-disease/epclusa/epclusa_pi.pdf
is a pyridone indicated for the treatment of idiopathic pulmonary fibrosis (IPF).
Manufactured by: Roche-Genentech, Inc.
Active Ingredient(s): Pirfenidone
Dosage Form: Capsules, Oral
Strength: 267 mg
FDA approved: October 15, 2014
More information about Esbriet:
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022535s000lbl.pdf